Pereira de Sa, Nivea http://orcid.org/0000-0003-0901-6909
Taouil, Adam
Kim, Jinwoo
Clement, Timothy
Hoffmann, Reece M.
Burke, John E. http://orcid.org/0000-0001-7904-9859
Rizzo, Robert C.
Ojima, Iwao http://orcid.org/0000-0002-3628-1161
Del Poeta, Maurizio
Airola, Michael V. http://orcid.org/0000-0003-4981-1253
Funding for this research was provided by:
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (NSERC-2020-04241)
Michael Smith Foundation for Health Research (Scholar Award 17686)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM126906, R35GM128666)
SUNY | Stony Brook University (1149556, 1149556)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI136934, AI116420, AI125770)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Burroughs Wellcome Fund
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Article History
Received: 28 July 2021
Accepted: 21 September 2021
First Online: 7 October 2021
Competing interests
: M.D.P. is a Co-Founder and Chief Scientific Officer (CSO) of MicroRid Technologies Inc. whose goal is to develop new antifungal agents of therapeutic use. The remaining authors declare no competing interests.